Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy.
Scharl M, Mwinyi J, Fischbeck A, Leucht K, Eloranta JJ, Arikkat J, Pesch T, Kellermeier S, Mair A, Kullak-Ublick GA, Truninger K, Noreen F, Regula J, Gaj P, Pittet V, Mueller C, Hofmann C, Fried M, McCole DF, Rogler G. Scharl M, et al. Among authors: pittet v. Inflamm Bowel Dis. 2012 May;18(5):900-12. doi: 10.1002/ibd.21913. Epub 2011 Oct 21. Inflamm Bowel Dis. 2012. PMID: 22021207
Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness.
Juillerat P, Pittet V, Vader JP, Burnand B, Gonvers JJ, de Saussure P, Mottet C, Seibold F, Rogler G, Sagmeister M, Felley C, Michetti P, Froehlich F; Swiss IBD Cohort Study Group. Juillerat P, et al. Among authors: pittet v. Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1352-7. doi: 10.1097/meg.0b013e32833eaa8a. Eur J Gastroenterol Hepatol. 2010. PMID: 20964261
Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.
Voegtlin M, Vavricka SR, Schoepfer AM, Straumann A, Voegtlin J, Rogler G, Ballabeni P, Pittet V, Buser A, Fried M, Beglinger C; Swiss IBD Cohort Study. Voegtlin M, et al. Among authors: pittet v. J Crohns Colitis. 2010 Dec;4(6):642-8. doi: 10.1016/j.crohns.2010.07.008. Epub 2010 Aug 12. J Crohns Colitis. 2010. PMID: 21122574
Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.
Vavricka SR, Spigaglia SM, Rogler G, Pittet V, Michetti P, Felley C, Mottet C, Braegger CP, Rogler D, Straumann A, Bauerfeind P, Fried M, Schoepfer AM; Swiss IBD Cohort Study Group. Vavricka SR, et al. Among authors: pittet v. Inflamm Bowel Dis. 2012 Mar;18(3):496-505. doi: 10.1002/ibd.21719. Epub 2011 Apr 20. Inflamm Bowel Dis. 2012. PMID: 21509908
Effects of social support on the clinical course of Crohn's disease.
Cámara RJ, Lukas PS, Begré S, Pittet V, von Känel R; Swiss Inflammatory Bowel Disease Cohort Study Group. Cámara RJ, et al. Among authors: pittet v. Inflamm Bowel Dis. 2011 Jun;17(6):1277-86. doi: 10.1002/ibd.21481. Epub 2010 Oct 25. Inflamm Bowel Dis. 2011. PMID: 21560191
Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.
Schoepfer AM, Beglinger C, Straumann A, Safroneeva E, Romero Y, Armstrong D, Schmidt C, Trummler M, Pittet V, Vavricka SR. Schoepfer AM, et al. Among authors: pittet v. Inflamm Bowel Dis. 2013 Feb;19(2):332-41. doi: 10.1097/MIB.0b013e3182810066. Inflamm Bowel Dis. 2013. PMID: 23328771 Clinical Trial.
Topical therapy is underused in patients with ulcerative colitis.
Seibold F, Fournier N, Beglinger C, Mottet C, Pittet V, Rogler G; Swiss IBD cohort study group. Seibold F, et al. Among authors: pittet v. J Crohns Colitis. 2014 Jan;8(1):56-63. doi: 10.1016/j.crohns.2013.03.005. Epub 2013 Apr 6. J Crohns Colitis. 2014. PMID: 23566922 Free article.
143 results